Saturday 17 October 2026 Export KPTI’s income statement to Excel — free account

Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc.’s revenue for fiscal 2025 (year ended December 2025) was $146.1 million, up 0.57% from fiscal 2024. In the quarter to June 2026, revenue fell 11.9%, EPS grew 46.3%, free cash flow fell 33.3% and total debt rose 36.6%, each against the same quarter a year earlier.

0.39 0.04 +11.43%

Follow KPTI

Alert me

Market cap: $8.0M
P/E: 0.0×
Fwd P/E: −2.1×
Dividend yield: —
F-score: 3/9
Altman Z: −23.89
Beneish M: −8.05
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	78.98%	82.70%	81.86%	58.11%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	2	2	3	3
ROA Full definition →	(207.90%)	(150.48%)	(143.71%)	(87.24%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	809.55%	(2,137.35%)	(1,751.91%)	(4,596.86%)
Average Days of Receivables Full definition →	74.36	56.41	65.42	81.63
Free Cash Flow per Share Full definition →	(2.26)	(2.69)	(6.89)	(10.31)
Free Cash Flow Full definition →	(65.35)	(59.11)	(75.37)	(89.35)
Other line items
Cash ROIC Full definition →	432.13%	(119.20%)	3,295.54%	263.67%
Accounts Receivable Turnover Full definition →	4.67	5.16	5.13	4.48
Accounts Payable Turnover Full definition →	1.18	1.18	1.31	1.04
Inventory Turnover Full definition →	1.34	1.43	1.36	1.34
Average Days of Payables Full definition →	463.90	260.61	245.60	339.56
Days of Inventory on Hand Full definition →	241.88	219.19	247.75	249.76
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	82.50%	82.58%	86.00%	92.09%
Selling, General and Administrative Expense of Revenue Full definition →	69.55%	69.18%	72.03%	76.91%
Share Based Compensation of Revenue Full definition →	7.94%	8.93%	9.62%	9.83%
Interest Coverage Full definition →	(1.67)	(1.78)	(1.98)	(2.34)
Operating CF/Net income Full definition →	0.29	0.30	0.38	0.72
Depreciation/Fixed assets Full definition →	108.29	114.21	100.31	82.16
Capex/Depreciation Full definition →	0.00	0.00	0.00	0.00
Revenue per Share Full definition →	5.07	6.86	13.36	16.44
Operating CF per Share Full definition →	(2.26)	(2.69)	(6.89)	(10.31)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly